ATE152613T1 - Zusammensetzung, die bei peroraler verabreichung eine mikroemulsion bildet - Google Patents

Zusammensetzung, die bei peroraler verabreichung eine mikroemulsion bildet

Info

Publication number
ATE152613T1
ATE152613T1 AT94928928T AT94928928T ATE152613T1 AT E152613 T1 ATE152613 T1 AT E152613T1 AT 94928928 T AT94928928 T AT 94928928T AT 94928928 T AT94928928 T AT 94928928T AT E152613 T1 ATE152613 T1 AT E152613T1
Authority
AT
Austria
Prior art keywords
composition
surfactant
esters
microemulsion
phase
Prior art date
Application number
AT94928928T
Other languages
English (en)
Inventor
Nabil Farah
Joel Denis
Original Assignee
Gattefosse Ets Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gattefosse Ets Sa filed Critical Gattefosse Ets Sa
Application granted granted Critical
Publication of ATE152613T1 publication Critical patent/ATE152613T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/37—Esters of carboxylic acids
    • A61K8/375—Esters of carboxylic acids the alcohol moiety containing more than one hydroxy group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/04—Dispersions; Emulsions
    • A61K8/06—Emulsions
    • A61K8/068—Microemulsions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/39—Derivatives containing from 2 to 10 oxyalkylene groups
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Birds (AREA)
  • Chemical & Material Sciences (AREA)
  • Emergency Medicine (AREA)
  • Dispersion Chemistry (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Dermatology (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Cosmetics (AREA)
AT94928928T 1993-09-30 1994-09-29 Zusammensetzung, die bei peroraler verabreichung eine mikroemulsion bildet ATE152613T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9311876A FR2710535B1 (fr) 1993-09-30 1993-09-30 Composition à usage pharmaceutique ou cosmétique apte à former une microémulsion.

Publications (1)

Publication Number Publication Date
ATE152613T1 true ATE152613T1 (de) 1997-05-15

Family

ID=9451565

Family Applications (1)

Application Number Title Priority Date Filing Date
AT94928928T ATE152613T1 (de) 1993-09-30 1994-09-29 Zusammensetzung, die bei peroraler verabreichung eine mikroemulsion bildet

Country Status (6)

Country Link
EP (1) EP0670715B1 (de)
AT (1) ATE152613T1 (de)
DE (1) DE69403057T2 (de)
ES (1) ES2101574T3 (de)
FR (1) FR2710535B1 (de)
WO (1) WO1995008983A1 (de)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6312704B1 (en) * 1993-09-30 2001-11-06 Gattefosse, S.A. Orally administrable composition capable of providing enhanced bioavailability when ingested
FR2729307B1 (fr) * 1995-01-18 1997-04-18 Seppic Sa Utilisation d'esters d'acides gras ethoxyles comme composants auto-emulsionnables notamment utiles pour la preparation de produits de traitement phytosanitaires ou de medicaments a usage veterinaire ou humain
WO1999029316A1 (en) 1997-12-10 1999-06-17 Severson, Mary, L. Pharmaceutical compositions containing an omega-3 fatty acid oil
US6979456B1 (en) 1998-04-01 2005-12-27 Jagotec Ag Anticancer compositions
AU3843999A (en) * 1998-05-07 1999-11-23 Elan Corporation, Plc Solvent/cosolvent free microemulsion and emulsion preconcentrate drug delivery systems
FR2782006B1 (fr) * 1998-08-07 2002-04-19 Gattefosse Ets Sa Composition a liberation prolongee apte a former une micro-emulsion
JP2000237284A (ja) * 1999-02-17 2000-09-05 Shionogi Qualicaps Kk 硬質カプセル製剤
GB9912476D0 (en) 1999-05-28 1999-07-28 Novartis Ag Organic compounds
FR2794023B1 (fr) * 1999-05-28 2003-04-25 Codif Internat Sa Composition cosmetique destinee a renforcer l'efficacite des principes actifs d'autres compositions cosmetiques
SE0000774D0 (sv) * 2000-03-08 2000-03-08 Astrazeneca Ab New formulation
SE0000773D0 (sv) * 2000-03-08 2000-03-08 Astrazeneca Ab New formulation
KR100426346B1 (ko) * 2000-11-30 2004-04-08 한국화학연구원 자가미세유화형 약물전달시스템을 이용한 고지혈증치료용약제 조성물
JP4350378B2 (ja) * 2001-03-29 2009-10-21 日清オイリオグループ株式会社 乳化化粧料及び外用剤
FR2827770B1 (fr) * 2001-07-27 2005-08-19 Gattefosse Ets Sa Composition pharmaceutique a usage oral comprenant un principe actif susceptible de subir un important effet de premier passage intestinal
SE0102993D0 (sv) 2001-09-07 2001-09-07 Astrazeneca Ab New self emulsifying drug delivery system
SE0200154D0 (sv) * 2002-01-21 2002-01-21 Galenica Ab New process
KR101152470B1 (ko) 2003-08-13 2012-06-01 바이오콘 리미티드 치료제용 마이크로-입자 지방산 염 고형 투약 제형
WO2005037251A1 (en) * 2003-10-17 2005-04-28 Amylin Pharmaceuticals, Inc. Self-emulsifying drug delivery systems for hydrophobic therapeutic compounds
WO2005037250A1 (en) * 2003-10-17 2005-04-28 Amylin Pharmaceuticals, Inc. Self emulsifying drug delivery systems for hydrophobic therapeutic compounds
CA2560613C (en) * 2004-03-22 2015-11-24 Solvay Pharmaceuticals Gmbh Oral pharmaceutical compositions of lipase-containing products, in particular of pancreatin, containing surfactants
FR2873585B1 (fr) * 2004-07-27 2006-11-17 Aventis Pharma Sa Nouvelles formulations galeniques de principes actifs
KR101555058B1 (ko) 2005-07-29 2015-09-22 애보트 래버러토리즈 게엠베하 살균된 판크레아틴 분말의 제조방법
US9198871B2 (en) 2005-08-15 2015-12-01 Abbott Products Gmbh Delayed release pancreatin compositions
US11266607B2 (en) 2005-08-15 2022-03-08 AbbVie Pharmaceuticals GmbH Process for the manufacture and use of pancreatin micropellet cores
US10072256B2 (en) 2006-05-22 2018-09-11 Abbott Products Gmbh Process for separating and determining the viral load in a pancreatin sample
CN101687044B (zh) * 2007-05-25 2014-10-29 不列颠哥伦比亚大学 用于口服给药的治疗剂的制剂和相关方法
WO2011050457A1 (en) 2009-10-26 2011-05-05 The University Of British Columbia Stabilized formulation for oral administration of therapeutic agents and related methods
DE102012019029A1 (de) 2012-09-27 2014-03-27 Alf Lamprecht Arzneiformulierungen zur oralen Gabe von therapeutischen Substanzen und Verfahren zur Herstellung
EP3215181B1 (de) 2014-11-05 2024-12-18 Abbott Laboratories GmbH Verfahren zur herstellung von zusammensetzungen mit pankreatin mit verbessertem sicherheitsprofil und zusammensetzungen, welche zur pharmazeutischen verwendung geeignet sind
WO2016126970A1 (en) 2015-02-04 2016-08-11 Abbvie Inc. Pharmaceutical compositions and methods of use thereof to treat pancreatic enzyme insufficiency
FR3073415B1 (fr) 2017-11-10 2019-11-08 Gattefosse Sas Systeme auto-emulsionnable solide et son procede de fabrication par impression en 3 dimensions

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3406497A1 (de) * 1984-02-23 1985-09-05 Mueller Bernhard Willi Werner Hochdisperse pharmazeutische mehrkomponentensysteme und verfahren zu ihrer herstellung
US5314685A (en) * 1992-05-11 1994-05-24 Agouron Pharmaceuticals, Inc. Anhydrous formulations for administering lipophilic agents

Also Published As

Publication number Publication date
FR2710535A1 (fr) 1995-04-07
WO1995008983A1 (fr) 1995-04-06
DE69403057D1 (de) 1997-06-12
FR2710535B1 (fr) 1995-11-24
EP0670715A1 (de) 1995-09-13
EP0670715B1 (de) 1997-05-07
DE69403057T2 (de) 1997-08-14
ES2101574T3 (es) 1997-07-01

Similar Documents

Publication Publication Date Title
ATE152613T1 (de) Zusammensetzung, die bei peroraler verabreichung eine mikroemulsion bildet
US5741766A (en) Oil-in-water cleansing emulsion having the appearance of milk
CA2313024A1 (en) Pharmaceutical compositions containing an omega-3 fatty acid oil
KR960021056A (ko) 사이클로스포린-함유 연질캅셀제 조성물
IL102633A0 (en) Compositions
IT1281337B1 (it) Preparazione farmaceutica orale contenente ciclosporina come sostanza attiva ed un preconcentrato di emulsione multipla
CA2072509A1 (en) Cyclosporin emulsion compositions for oral administration
KR960016904A (ko) 사이클로스포린-함유 연질캅셀제 조성물
AP2000001943A0 (en) Orally administrable immediate-release and prolonged-release galenic form comprising an absorption-promoting agent and use of this absorption-promoting agent.
ES2207714T3 (es) Formulacion de ciclosporina.
DK0904064T3 (da) Orale farmaceutiske præparater indeholdende kønshormoner
EE03425B1 (et) Lihtsa koostise ja kõrge biosaadavusega tsüklosporiini preparaadid suu kaudu manustamiseks ja nende valmistamismeetod
KR970064620A (ko) 사이클로스포린-함유 외용약제 조성물
KR100352088B1 (ko) 미녹시딜 함유 외용 에멀젼 조성물
MX9204382A (es) Composiciones
ATE404172T1 (de) Dispergierbares konzentrat zur verabreichung von cyclosporin
KR970706803A (ko) 경구용 시클로스포린 제형(oral cyclosporin formulations)
MY117765A (en) Cyclosporin-containing soft capsule preparations.
EP0517412A1 (de) Pharmazeutische Zusammensetzungen enthaltend eine Benzodiazepen
RU99121398A (ru) Фармацевтические композиции
IE921688A1 (en) Pharmaceutical Formulations containing a Benzodiazepine IE
CA2572498A1 (en) Biphasic capsule formulation

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties